CO5560609A2 - Oxazolidinona y/o isoxazolina como agentes antibacteriales - Google Patents
Oxazolidinona y/o isoxazolina como agentes antibacterialesInfo
- Publication number
- CO5560609A2 CO5560609A2 CO04021466A CO04021466A CO5560609A2 CO 5560609 A2 CO5560609 A2 CO 5560609A2 CO 04021466 A CO04021466 A CO 04021466A CO 04021466 A CO04021466 A CO 04021466A CO 5560609 A2 CO5560609 A2 CO 5560609A2
- Authority
- CO
- Colombia
- Prior art keywords
- independently selected
- groups
- isoxazoline
- oxazolidinone
- antibacterial agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
1.- Un compuesto de la fórmula (I), o una sal farmacéuticamente aceptable, o un éster hidrolizable in-vivo de este, En donde (I) C es una mitad biaril C'-C"Donde C´ y C" son independientemente anillos de arilo o heteroarilo de forma que el fragmento central C está representado por cualquiera de los grupos D a L siguientes:donde los grupos D a L pueden estar pegados a los anillos A y B en cualquier orientación; En donde A y B son seleccionados independientemente de donde i) y/o ii están enlazados como se muestra en (I) mediante la posición 3 al grupo C y sustituido en la posición 5 como se muestra en (I) por -CH2-R1a y -CH2-R1b;R2a, R2b, R3a y R3b son independientemente hidrógeno o flúor;R1a y R1b son independientemente seleccionados de hidroxi, -Osi(tri-alquilo(1-6C) (donde los 3 grupos alquilo(1-6C) son independientemente seleccionados de todos los posibles grupos alquilo(1-6C), -NHC(=W)R4, -OC(=O)R4, donde W es O o S; ...
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0121942A GB0121942D0 (en) | 2001-09-11 | 2001-09-11 | Chemical compounds |
GB0215420A GB0215420D0 (en) | 2002-07-04 | 2002-07-04 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
CO5560609A2 true CO5560609A2 (es) | 2005-09-30 |
Family
ID=26246531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO04021466A CO5560609A2 (es) | 2001-09-11 | 2004-03-09 | Oxazolidinona y/o isoxazolina como agentes antibacteriales |
Country Status (26)
Country | Link |
---|---|
US (2) | US7396847B2 (es) |
EP (1) | EP1427711B1 (es) |
JP (1) | JP2005507386A (es) |
KR (1) | KR20040044886A (es) |
CN (1) | CN1639136A (es) |
AR (1) | AR036778A1 (es) |
AT (1) | ATE299502T1 (es) |
AU (1) | AU2002329393B2 (es) |
BR (1) | BR0212458A (es) |
CA (1) | CA2459766A1 (es) |
CO (1) | CO5560609A2 (es) |
DE (1) | DE60205030T2 (es) |
DK (1) | DK1427711T3 (es) |
ES (1) | ES2244802T3 (es) |
HK (1) | HK1065789A1 (es) |
HU (1) | HUP0401005A3 (es) |
IL (1) | IL160739A0 (es) |
IS (1) | IS7175A (es) |
MX (1) | MXPA04002303A (es) |
NO (1) | NO327010B1 (es) |
NZ (1) | NZ531621A (es) |
PL (1) | PL369183A1 (es) |
PT (1) | PT1427711E (es) |
RU (1) | RU2004111285A (es) |
SI (1) | SI1427711T1 (es) |
WO (1) | WO2003022824A1 (es) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6667299B1 (en) * | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
WO2003035073A1 (en) | 2001-10-25 | 2003-05-01 | Astrazeneca Ab | Isoxazoline derivatives useful as antimicrobials |
PL372090A1 (en) | 2002-02-28 | 2005-07-11 | Astrazeneca Ab | Chemical compounds |
IL163688A0 (en) | 2002-02-28 | 2005-12-18 | Astrazeneca Ab | 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents |
IL164487A0 (en) * | 2002-04-25 | 2005-12-18 | Basf Ag | 3-Heteroaryl substituted 5-methyloxymethyl isoxazolines used as herbicides |
AR043050A1 (es) * | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
KR20050084010A (ko) * | 2002-11-28 | 2005-08-26 | 아스트라제네카 아베 | 항균제로서의 옥사졸리디논 |
EP1567532A1 (en) * | 2002-11-28 | 2005-08-31 | Astrazeneca AB | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
GB0227701D0 (en) * | 2002-11-28 | 2003-01-08 | Astrazeneca Ab | Chemical compounds |
GB0229522D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
GB0229521D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
GB0229526D0 (en) * | 2002-12-19 | 2003-01-22 | Astrazeneca Ab | Chemical compounds |
GB0304723D0 (en) * | 2003-03-01 | 2003-04-02 | Astrazeneca Ab | Chemical compounds |
TW200500360A (en) * | 2003-03-01 | 2005-01-01 | Astrazeneca Ab | Hydroxymethyl compounds |
US6969726B2 (en) | 2003-06-03 | 2005-11-29 | Rib X Pharmaceuticals Inc | Biaryl heterocyclic compounds and methods of making and using the same |
US8324398B2 (en) | 2003-06-03 | 2012-12-04 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
WO2005012271A2 (en) * | 2003-07-29 | 2005-02-10 | Rib-X Pharmaceuticals, Inc. | Process for the synthesis of biaryl oxazolidinones |
JP4777246B2 (ja) * | 2003-07-29 | 2011-09-21 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | ビアリールオキサゾリジノンの合成方法 |
JP2007514782A (ja) | 2003-12-17 | 2007-06-07 | リブ−エックス ファーマシューティカルズ,インコーポレイテッド | ハロゲン化ビアリール複素環式化合物ならびにその作製方法および使用方法 |
KR100854211B1 (ko) | 2003-12-18 | 2008-08-26 | 동아제약주식회사 | 신규한 옥사졸리디논 유도체, 그의 제조방법 및 이를유효성분으로 하는 항생제용 약학 조성물 |
EP2716647A3 (en) | 2004-02-27 | 2014-08-20 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
US20080064689A1 (en) * | 2004-05-25 | 2008-03-13 | Astrazeneca Ab | 3-[4-(6-Pyridin-3-Yl)-3-Phenyl] -5-(1H-1,2,3-Triazol-1-Ylmethyl)-1,3-Oxazolidin-2-Ones as Antibacterial Agents |
CA2567457A1 (en) * | 2004-05-25 | 2005-12-08 | Astrazeneca Ab | 3- (4- (2-dihydroisoxazol-3-ylpyridin-5-yl) phenyl) -5-triazol-1-ylmethyloxazolidin-2-one derivaives as mao inhibitors for the treatment of bacterial infections |
GB0411596D0 (en) * | 2004-05-25 | 2004-06-30 | Astrazeneca Ab | Chemical process |
DOP2005000123A (es) | 2004-07-02 | 2011-07-15 | Merck Sharp & Dohme | Inhibidores de cetp |
WO2006038100A1 (en) * | 2004-10-08 | 2006-04-13 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
US7592335B2 (en) | 2005-04-15 | 2009-09-22 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
KR101394307B1 (ko) | 2005-06-08 | 2014-05-13 | 멜린타 테라퓨틱스, 인크. | 트리아졸의 합성 방법 |
EP1934237A2 (en) | 2005-08-24 | 2008-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
EP1928893A2 (en) | 2005-08-24 | 2008-06-11 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
SG195544A1 (en) | 2008-10-10 | 2013-12-30 | Trius Therapeutics | Methods for preparing oxazolidinones and compositions containing them |
CA2751392C (en) | 2009-02-03 | 2017-03-28 | Trius Therapeutics, Inc. | Crystalline form of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate |
US8580767B2 (en) | 2009-05-28 | 2013-11-12 | Trius Therapeutics, Inc. | Oxazolidinone containing dimer compounds, compositions and methods to make and use |
KR101561964B1 (ko) | 2013-11-15 | 2015-10-20 | 한국과학기술연구원 | 옥사졸리디논 화합물 및 이를 포함하는 c형 간염 예방 또는 치료용 약학 조성물 |
WO2016136963A1 (ja) * | 2015-02-27 | 2016-09-01 | 彰彦 石川 | カケロマイシンおよびその誘導体の製造方法 |
CN106083994B (zh) * | 2016-04-18 | 2019-12-06 | 南京曼杰生物科技有限公司 | 取代的噁唑烷酮水溶性衍生物及其应用 |
US20170333305A1 (en) * | 2016-05-23 | 2017-11-23 | Microban Products Company | Topical skin product having retention property |
US11452719B2 (en) | 2017-12-13 | 2022-09-27 | Merck Sharp & Dohme Llc | Pharmaceutical compositions of tedizolid phosphate |
CN113149924B (zh) * | 2021-03-29 | 2023-11-03 | 苏州大学 | 一种异噁唑啉的简单制备方法 |
CN113831517A (zh) * | 2021-09-09 | 2021-12-24 | 万凯新材料股份有限公司 | 抗菌及抗紫外聚酯的制备方法 |
Family Cites Families (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5043443A (en) * | 1988-07-29 | 1991-08-27 | Du Pont Merck Pharmaceutical Company | Aminomethyloxooxazolidinyl arylbenzene derivatives |
US4948801A (en) | 1988-07-29 | 1990-08-14 | E. I. Du Pont De Nemours And Company | Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents |
SK283420B6 (sk) * | 1992-05-08 | 2003-07-01 | Pharmacia & Upjohn Company | Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny |
GB9521508D0 (en) | 1995-10-20 | 1995-12-20 | Zeneca Ltd | Chemical compounds |
GB9601666D0 (en) | 1996-01-27 | 1996-03-27 | Zeneca Ltd | Chemical compounds |
GB9702213D0 (en) | 1996-02-24 | 1997-03-26 | Zeneca Ltd | Chemical compounds |
GB9604301D0 (en) | 1996-02-29 | 1996-05-01 | Zeneca Ltd | Chemical compounds |
GB9609919D0 (en) | 1996-05-11 | 1996-07-17 | Zeneca Ltd | Chemical compounds |
GB9614236D0 (en) | 1996-07-06 | 1996-09-04 | Zeneca Ltd | Chemical compounds |
GB9614238D0 (en) | 1996-07-06 | 1996-09-04 | Zeneca Ltd | Chemical compounds |
GB9717804D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
GB9717807D0 (en) | 1997-08-22 | 1997-10-29 | Zeneca Ltd | Chemical compounds |
AU8872198A (en) | 1997-08-29 | 1999-03-22 | Zeneca Limited | Aminometyl oxooxazolidinyl benzene derivatives |
GB9725244D0 (en) | 1997-11-29 | 1998-01-28 | Zeneca Ltd | Chemical compounds |
AU1694099A (en) | 1997-12-26 | 1999-07-19 | Cheil Jedang Corporation | Cephem derivatives and a method for producing the compounds and an antibacterialcomposition containing the compounds |
GB9812019D0 (en) | 1998-06-05 | 1998-07-29 | Zeneca Ltd | Chemical compounds |
EP1082323A2 (en) | 1998-06-05 | 2001-03-14 | AstraZeneca UK Limited | Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
AU4543899A (en) | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
GB9821938D0 (en) | 1998-10-09 | 1998-12-02 | Zeneca Ltd | Chemical compounds |
GB9928499D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical processes and intermediates |
GB9928568D0 (en) | 1999-12-03 | 2000-02-02 | Zeneca Ltd | Chemical compounds |
GB0009803D0 (en) | 2000-04-25 | 2000-06-07 | Astrazeneca Ab | Chemical compounds |
CA2411859A1 (en) * | 2000-06-05 | 2001-12-13 | Jae-Gul Lee | Novel oxazolidinone derivatives and a process for the preparation thereof |
DE10034624A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Aryl-substituierte Thienyl-1,3-oxazolidin-2-one als Cytokin-Inhibitoren |
DE10034625A1 (de) | 2000-07-17 | 2002-01-31 | Bayer Ag | Heterocyclisch substituierte Thienyl-Phenyl-Oxazolidinone |
US20020115669A1 (en) * | 2000-08-31 | 2002-08-22 | Wiedeman Paul E. | Oxazolidinone chemotherapeutic agents |
YU52403A (sh) | 2000-12-26 | 2006-03-03 | Dr.Reddy's Research Foundation | Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže |
ES2268011T3 (es) | 2001-04-07 | 2007-03-16 | Astrazeneca Ab | Oxazolidinonas que contienen un grupo sulfonimida como antibioticos. |
GB0108793D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
GB0108794D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compound |
GB0108764D0 (en) | 2001-04-07 | 2001-05-30 | Astrazeneca Ab | Chemical compounds |
GB0113299D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical process & intermediates |
GB0113298D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Purification process and intermediates |
GB0113300D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Purification process |
GB0113297D0 (en) | 2001-06-01 | 2001-07-25 | Astrazeneca Ab | Chemical Process |
AU2002354579A1 (en) | 2001-07-12 | 2003-01-29 | Pharmacia And Upjohn Company | Amide-containing compound having improved solubility and method of improving the solubility of an amide-containing compound |
GB0118407D0 (en) | 2001-07-27 | 2001-09-19 | Cipla Ltd | Oxazolidinone derivatives as antibacterial agents |
WO2003031441A1 (en) | 2001-10-04 | 2003-04-17 | Morphochen Aktiengesellschaft Für Kombinatorische Chemie | Multiple action compounds |
WO2003031443A1 (en) | 2001-10-04 | 2003-04-17 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Dual actions antibiotics comprising a oxazoldinone and a quinolone or naphthyridinone moiety |
WO2003035073A1 (en) | 2001-10-25 | 2003-05-01 | Astrazeneca Ab | Isoxazoline derivatives useful as antimicrobials |
EP1446403B1 (en) | 2001-10-25 | 2006-04-12 | AstraZeneca AB | Aryl substituted oxazolidinones with antibacterial activity |
IL163688A0 (en) | 2002-02-28 | 2005-12-18 | Astrazeneca Ab | 3-Cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and theiruse as antibacterial agents |
PL372090A1 (en) | 2002-02-28 | 2005-07-11 | Astrazeneca Ab | Chemical compounds |
JP2003335762A (ja) | 2002-05-20 | 2003-11-28 | Meiji Seika Kaisha Ltd | 新規ビフェニル誘導体 |
AR043050A1 (es) | 2002-09-26 | 2005-07-13 | Rib X Pharmaceuticals Inc | Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos |
EP1567532A1 (en) * | 2002-11-28 | 2005-08-31 | Astrazeneca AB | Oxazolidinone and / or isoxazoline derivatives as antibacterial agents |
-
2002
- 2002-09-09 WO PCT/GB2002/004120 patent/WO2003022824A1/en active IP Right Grant
- 2002-09-09 HU HU0401005A patent/HUP0401005A3/hu unknown
- 2002-09-09 DK DK02765019T patent/DK1427711T3/da active
- 2002-09-09 JP JP2003526899A patent/JP2005507386A/ja active Pending
- 2002-09-09 DE DE60205030T patent/DE60205030T2/de not_active Expired - Fee Related
- 2002-09-09 MX MXPA04002303A patent/MXPA04002303A/es active IP Right Grant
- 2002-09-09 BR BR0212458-0A patent/BR0212458A/pt not_active IP Right Cessation
- 2002-09-09 NZ NZ531621A patent/NZ531621A/en unknown
- 2002-09-09 PT PT02765019T patent/PT1427711E/pt unknown
- 2002-09-09 AU AU2002329393A patent/AU2002329393B2/en not_active Ceased
- 2002-09-09 EP EP02765019A patent/EP1427711B1/en not_active Expired - Lifetime
- 2002-09-09 IL IL16073902A patent/IL160739A0/xx unknown
- 2002-09-09 PL PL02369183A patent/PL369183A1/xx not_active Application Discontinuation
- 2002-09-09 US US10/489,266 patent/US7396847B2/en not_active Expired - Fee Related
- 2002-09-09 ES ES02765019T patent/ES2244802T3/es not_active Expired - Lifetime
- 2002-09-09 CN CNA028223276A patent/CN1639136A/zh active Pending
- 2002-09-09 RU RU2004111285/04A patent/RU2004111285A/ru not_active Application Discontinuation
- 2002-09-09 CA CA002459766A patent/CA2459766A1/en not_active Abandoned
- 2002-09-09 KR KR10-2004-7003558A patent/KR20040044886A/ko not_active Application Discontinuation
- 2002-09-09 AT AT02765019T patent/ATE299502T1/de not_active IP Right Cessation
- 2002-09-09 SI SI200230188T patent/SI1427711T1/sl unknown
- 2002-09-11 AR ARP020103440A patent/AR036778A1/es unknown
-
2004
- 2004-03-09 CO CO04021466A patent/CO5560609A2/es not_active Application Discontinuation
- 2004-03-10 IS IS7175A patent/IS7175A/is unknown
- 2004-04-05 NO NO20041428A patent/NO327010B1/no not_active IP Right Cessation
- 2004-10-29 HK HK04108506A patent/HK1065789A1/xx not_active IP Right Cessation
-
2008
- 2008-05-28 US US12/128,135 patent/US20100137243A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IS7175A (is) | 2004-03-10 |
NO20041428L (no) | 2004-06-08 |
AU2002329393B2 (en) | 2008-06-12 |
NZ531621A (en) | 2005-06-24 |
CA2459766A1 (en) | 2003-03-20 |
WO2003022824A1 (en) | 2003-03-20 |
HUP0401005A3 (en) | 2007-11-28 |
DE60205030D1 (de) | 2005-08-18 |
HK1065789A1 (en) | 2005-03-04 |
MXPA04002303A (es) | 2004-06-29 |
EP1427711A1 (en) | 2004-06-16 |
EP1427711B1 (en) | 2005-07-13 |
CN1639136A (zh) | 2005-07-13 |
ATE299502T1 (de) | 2005-07-15 |
NO327010B1 (no) | 2009-04-06 |
HUP0401005A2 (hu) | 2004-08-30 |
AR036778A1 (es) | 2004-10-06 |
PT1427711E (pt) | 2005-11-30 |
DE60205030T2 (de) | 2006-04-20 |
US20050107435A1 (en) | 2005-05-19 |
RU2004111285A (ru) | 2005-10-10 |
IL160739A0 (en) | 2004-08-31 |
BR0212458A (pt) | 2004-10-19 |
PL369183A1 (en) | 2005-04-18 |
US20100137243A1 (en) | 2010-06-03 |
KR20040044886A (ko) | 2004-05-31 |
US7396847B2 (en) | 2008-07-08 |
ES2244802T3 (es) | 2005-12-16 |
JP2005507386A (ja) | 2005-03-17 |
DK1427711T3 (da) | 2005-10-17 |
SI1427711T1 (sl) | 2005-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO5560609A2 (es) | Oxazolidinona y/o isoxazolina como agentes antibacteriales | |
CO5280078A1 (es) | Compuestos | |
AR027406A1 (es) | Moduladores de receptores canabinoides, sus procesos de preparacion y uso de los moduladores de receptores canabinoides para el tratamiento de enfermedadesrespiratorias y no respiratorias. | |
AR030186A1 (es) | Compuesto antibacteriano 3-aminoquinazolina-2,4-diona, composicion farmaceutica que lo comprende y su uso para fabricarla | |
PT1159279E (pt) | 4-oxo-4,7-di-hidrotieno¬2,3-b|piridino-5-carboxamidas como agentes antivirais | |
HRP20020938B1 (en) | Tropane derivatives useful in therapy | |
ES2077948T3 (es) | Preparacion para el cuidado externo de la piel. | |
AR020851A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos | |
WO2003024441A1 (fr) | Nouvelle utilisation de composes tricycliques | |
CR8790A (es) | Composiciones quimicas | |
PT95808A (pt) | Processo para a preparacao de novos derivados de 1,2-benzisoxazol | |
UY24268A1 (es) | Composiciones estables de vacunas para la administración parenteral, método para su utilización | |
AR043436A1 (es) | Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6 | |
DE122005000058I1 (de) | Depsipeptide, Herstellung und Anwendung | |
DK0636622T3 (da) | Isoxazolderivater samt deres anvendelse som herbicider | |
AR024077A1 (es) | Compuestos antibacterianos | |
BR0010366A (pt) | Composto, composição farmacêutica, método de preparar um composto, e, composto para uso em terapia | |
ES2170101T3 (es) | Compuesto ciclodepsipeptido. | |
DE60318826D1 (de) | Alkoxypyridinderivate | |
AR037940A1 (es) | Compuestos antivirales de piridoquinoxalina | |
AR078683A1 (es) | Compuesto de pirona y su uso para el control de plagas | |
TW200502697A (en) | Polyester compound with sulfonamide structure, polymer, photoresist and patterning process | |
TW200505446A (en) | Inhibitor of cox | |
FI945227A (fi) | Sykliset heksapeptidit, niiden valmistus ja käyttö | |
EA200601110A1 (ru) | Производные спиропиперидина, предназначенные для борьбы с вредителями |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Application withdrawn |